ATE198711T1 - Gammaglobuline enthaltende immunotherapeutische präparate für die behandlung von krebskrankheiten - Google Patents

Gammaglobuline enthaltende immunotherapeutische präparate für die behandlung von krebskrankheiten

Info

Publication number
ATE198711T1
ATE198711T1 AT95912808T AT95912808T ATE198711T1 AT E198711 T1 ATE198711 T1 AT E198711T1 AT 95912808 T AT95912808 T AT 95912808T AT 95912808 T AT95912808 T AT 95912808T AT E198711 T1 ATE198711 T1 AT E198711T1
Authority
AT
Austria
Prior art keywords
preparation
methods
gammaglobulines
treatment
preparations containing
Prior art date
Application number
AT95912808T
Other languages
English (en)
Inventor
Yehuda Shoenfeld
Pnina Fishman
Original Assignee
Arp Biomed Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26907064&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE198711(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Arp Biomed Ltd filed Critical Arp Biomed Ltd
Application granted granted Critical
Publication of ATE198711T1 publication Critical patent/ATE198711T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/54—F(ab')2

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT95912808T 1994-03-14 1995-03-09 Gammaglobuline enthaltende immunotherapeutische präparate für die behandlung von krebskrankheiten ATE198711T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21236194A 1994-03-14 1994-03-14
US08/340,094 US5562902A (en) 1994-03-14 1994-11-15 Immunotherapeutic method of treating cancerous diseases by administration of intravenous immunoglobulin
PCT/US1995/002910 WO1995024927A1 (en) 1994-03-14 1995-03-09 Immunotherapeutic method of treating cancerous diseases by administration of gamma globulins

Publications (1)

Publication Number Publication Date
ATE198711T1 true ATE198711T1 (de) 2001-02-15

Family

ID=26907064

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95912808T ATE198711T1 (de) 1994-03-14 1995-03-09 Gammaglobuline enthaltende immunotherapeutische präparate für die behandlung von krebskrankheiten

Country Status (20)

Country Link
US (2) US5562902A (de)
EP (1) EP0750514B1 (de)
JP (2) JP4004062B2 (de)
KR (1) KR100352583B1 (de)
CN (1) CN1089007C (de)
AT (1) ATE198711T1 (de)
AU (1) AU700751B2 (de)
BR (1) BR9507067A (de)
CA (1) CA2184269A1 (de)
DE (1) DE69519924T2 (de)
DK (1) DK0750514T3 (de)
ES (1) ES2155519T3 (de)
FI (1) FI114011B (de)
GR (1) GR3035758T3 (de)
HK (1) HK1014493A1 (de)
IL (1) IL112963A (de)
NZ (1) NZ282659A (de)
PT (1) PT750514E (de)
TW (1) TW418091B (de)
WO (1) WO1995024927A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070166313A1 (en) * 1994-03-14 2007-07-19 Yehuda Shoenfeld Administration of gamma globulins to treat cancer
US20080050390A1 (en) * 1994-03-14 2008-02-28 Yehuda Shoenfeld Administration of gamma globulins to treat metastatic melanoma
EP1076665A1 (de) 1998-05-07 2001-02-21 Research Corporation Technologies, Inc Orale verabreichung von immunoglobulinen zur behandlung des autoimmunen hörverlustes
TWI248819B (en) * 1999-09-27 2006-02-11 Arp Biomed Ltd Pharmaceutical composition containing IVIG for use in treating lymphoma
WO2001066124A2 (en) * 2000-03-10 2001-09-13 Medinnova Sf Composition for the treatment of heart failure
AT410637B (de) * 2001-06-01 2003-06-25 Igeneon Krebs Immuntherapie Verwendung von polyklonalen immunglobulinen
AU2002306251A1 (en) 2002-02-15 2003-09-04 Richard Brunner 7s immunoglobulin for treatment of choroidal neovascularisation_
US20080031903A1 (en) * 2006-07-27 2008-02-07 Andrea Gambotto Method of treating ocular infections
US20090053217A1 (en) * 2007-05-07 2009-02-26 Miri Blank Human anti-VEGF polyclonal antibodies and uses thereof
WO2010093606A1 (en) * 2009-02-11 2010-08-19 Martin Heath Bluth Reciprocal serum/plasma exchange for the treatment of cancer
CN114129722B (zh) * 2020-09-04 2024-04-05 中国医学科学院输血研究所 注射用人免疫球蛋白在制备预防或治疗辐照损伤的药物中的用途
CN114392351B (zh) * 2021-07-13 2024-04-05 中国医学科学院放射医学研究所 毛螺菌科细菌与注射用人免疫球蛋白的联合用药物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4699783A (en) * 1983-03-11 1987-10-13 Terman David S Products and methods for treatment of cancer
US4834975A (en) * 1984-05-25 1989-05-30 Genetics Corporation Human monoclonal antibodies to serotypic lipopolysaccharide determinants on gram-negative bacteria and their production
US4699784A (en) * 1986-02-25 1987-10-13 Center For Molecular Medicine & Immunology Tumoricidal methotrexate-antibody conjugate
TWI248819B (en) * 1999-09-27 2006-02-11 Arp Biomed Ltd Pharmaceutical composition containing IVIG for use in treating lymphoma

Also Published As

Publication number Publication date
EP0750514B1 (de) 2001-01-17
PT750514E (pt) 2001-06-29
DE69519924D1 (de) 2001-02-22
US5562902A (en) 1996-10-08
DE69519924T2 (de) 2001-08-23
IL112963A0 (en) 1995-06-29
FI963598A0 (fi) 1996-09-12
EP0750514A1 (de) 1997-01-02
KR100352583B1 (ko) 2002-12-26
AU1984895A (en) 1995-10-03
CA2184269A1 (en) 1995-09-21
FI963598A (fi) 1996-09-12
DK0750514T3 (da) 2001-05-21
WO1995024927A1 (en) 1995-09-21
FI114011B (fi) 2004-07-30
JPH09512791A (ja) 1997-12-22
CN1148343A (zh) 1997-04-23
BR9507067A (pt) 1997-09-30
GR3035758T3 (en) 2001-07-31
JP4004062B2 (ja) 2007-11-07
ES2155519T3 (es) 2001-05-16
AU700751B2 (en) 1999-01-14
NZ282659A (en) 1998-06-26
IL112963A (en) 2000-02-17
JP2007119493A (ja) 2007-05-17
US5965130A (en) 1999-10-12
CN1089007C (zh) 2002-08-14
HK1014493A1 (en) 1999-09-30
TW418091B (en) 2001-01-11

Similar Documents

Publication Publication Date Title
MY112405A (en) Method of tumer treatment.
ATE198711T1 (de) Gammaglobuline enthaltende immunotherapeutische präparate für die behandlung von krebskrankheiten
GR3032511T3 (en) Combination with anti-hormonal compounds and binding molecules for the treatment of cancer.
ATE260666T1 (de) Zellulärer impfstoff und deren verwendung für die behandlung von malignen, soliden tumoren
DE3789082D1 (de) Expression eines tumorspezifischen Antigens eines rekombinanten Virusvektors sowie dessen Anwendung zur versorgenden oder heilenden Behandlung des entsprechenden Tumors.
Rytömaa et al. Chloroma regression induced by the granulocytic chalone
ATE120372T1 (de) Antikörper für die antilymphozyten- antikörpertherapie.
DE60116075D1 (de) Behandlung von tumoren mit photodynamischer therapie
BR9808263A (pt) Processos para tratar câncer em um humano em necessidade de tratamento e para manufaturar um medicamento para inibir o crescimento em um humano de um tumor sólido, e, uso de um composto.
DE60033540D1 (de) Verabreichung von gammaglobulinen zur behandlung von lymphomen
WO2002074756A3 (de) Urokinase-inhibitoren
DE69942637D1 (de) Zusammensetzungen und verfahren für die therapie und diagnose von ovariumkrebs
RU2093219C1 (ru) Способ лечения рака пищевода
DE59009724D1 (de) Verwendung von 7-oh-1,2-benzopyron zur herstellung eines arzneimittels zur behandlung von malignen tumoren beim menschen.
DE59506911D1 (de) Verwendung von intravenös applizierbarem eisen zur therapie von tumorerkrankungen und/oder infektionskrankheiten
ATE345838T1 (de) Verfahren und mittel zur prävention, hemmung und therapie von krebserkrankungen
RU97114158A (ru) Способ лечения злокачественных опухолей

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee